Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer’s disease

Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer’s disease

Abstract Background The previously described and validated Erlangen Score (ES) algorithm enables interpretation of the cerebrospinal fluid (CSF) biomarkers of Alzheimer’s disease (AD), ordering them on an ordinal scale: from neurochemically normal (ES = 0) through improbable AD (ES = 1), possible AD...

Full description

Bibliographic Details
Main Authors: Inês Baldeiras, Isabel Santana, Maria João Leitão, Daniela Vieira, Diana Duro, Barbara Mroczko, Johannes Kornhuber, Piotr Lewczuk
Format: Article
Language:English
Published: BMC 2019-01-01
Series:Alzheimer’s Research & Therapy
Subjects:
Alzheimer’s disease
Mild cognitive impairment—progression
Cerebrospinal fluid
Biomarker
Online Access:http://link.springer.com/article/10.1186/s13195-018-0456-x

Internet

http://link.springer.com/article/10.1186/s13195-018-0456-x

Similar Items